The Journal of allergy and clinical immunology

Keyphrases

Publications

volume 151, number 2, 2023

Andrew Gibson, Pooja Deshpande, Chelsea N Campbell, Matthew S Krantz, Eric Mukherjee, Maja Mockenhaupt, Munir Pirmohamed, Amy M Palubinsky, Elizabeth J Phillips
Updates on the immunopathology and genomics of severe cutaneous adverse drug reactions. The Journal of allergy and clinical immunology 151 (2) (2023)
Andrew Gibson, Pooja Deshpande, Chelsea N Campbell, Matthew S Krantz, Eric Mukherjee, Maja Mockenhaupt, Munir Pirmohamed, Amy M Palubinsky, Elizabeth J Phillips
Updates on the immunopathology and genomics of severe cutaneous adverse drug reactions. The Journal of allergy and clinical immunology 151 (2) (2023)
Andrew Gibson, Pooja Deshpande, Chelsea N Campbell, Matthew S Krantz, Eric Mukherjee, Maja Mockenhaupt, Munir Pirmohamed, Amy M Palubinsky, Elizabeth J Phillips
Updates on the immunopathology and genomics of severe cutaneous adverse drug reactions. The Journal of allergy and clinical immunology 151 (2) (2023)
Andrew Gibson, Pooja Deshpande, Chelsea N Campbell, Matthew S Krantz, Eric Mukherjee, Maja Mockenhaupt, Munir Pirmohamed, Amy M Palubinsky, Elizabeth J Phillips
Updates on the immunopathology and genomics of severe cutaneous adverse drug reactions. The Journal of allergy and clinical immunology 151 (2) (2023)

volume 151, number 3, 2023

Jonathan M Spergel, George Du Toit, Carla M Davis
Might biologics serve to interrupt the atopic march? The Journal of allergy and clinical immunology 151 (3) (2023)
Jonathan M Spergel, George Du Toit, Carla M Davis
Might biologics serve to interrupt the atopic march? The Journal of allergy and clinical immunology 151 (3) (2023)
Hans Bisgaard, Bo Chawes, Jakob Stokholm, Marianne Mikkelsen, Ann-Marie Malby Schoos, Klaus Bønnelykke
25 Years of translational research in the Copenhagen Prospective Studies on Asthma in Childhood (COPSAC). The Journal of allergy and clinical immunology 151 (3) (2023)
Sneha Butala, Amy S Paller
Biologics in the management of childhood atopic dermatitis. The Journal of allergy and clinical immunology 151 (3) (2023)
Thomas Bieber
In search of the Holy Grail in atopic dermatitis: Will dupilumab become the first disease-modifying atopic dermatitis drug? The Journal of allergy and clinical immunology 151 (3) (2023)
Raffaele De Palma
Patients with CVID have their own "gut feeling" for viruses. The Journal of allergy and clinical immunology 151 (3) (2023)
Yan Du, Meng Liu, Peter A Nigrovic, Fatma Dedeoglu, Pui Y Lee
Biologics and JAK inhibitors for the treatment of monogenic systemic autoinflammatory diseases in children. The Journal of allergy and clinical immunology 151 (3) (2023)
Sneha Butala, Amy S Paller
Biologics in the management of childhood atopic dermatitis. The Journal of allergy and clinical immunology 151 (3) (2023)
Yan Du, Meng Liu, Peter A Nigrovic, Fatma Dedeoglu, Pui Y Lee
Biologics and JAK inhibitors for the treatment of monogenic systemic autoinflammatory diseases in children. The Journal of allergy and clinical immunology 151 (3) (2023)
Sayantani B Sindher, Suzanne Barshow, Jyothi Tirumalasetty, Stefania Arasi, Dan Atkins, Maureen Bauer, Philippe Bégin, Margaret H Collins, Antoine Deschildre, Alfred D Doyle, Alessandro Fiocchi, Glenn T Furuta, Maria Garcia-Lloret, Maurizio Mennini, Marc E Rothenberg, Jonathan M Spergel, Julie Wang, Robert A Wood, Benjamin L Wright, Torsten Zuberbier, Andrew R Chin, Andrew Long, Kari C Nadeau, R Sharon Chinthrajah
The role of biologics in pediatric food allergy and eosinophilic gastrointestinal disorders. The Journal of allergy and clinical immunology 151 (3) (2023)
Yan Du, Meng Liu, Peter A Nigrovic, Fatma Dedeoglu, Pui Y Lee
Biologics and JAK inhibitors for the treatment of monogenic systemic autoinflammatory diseases in children. The Journal of allergy and clinical immunology 151 (3) (2023)
Leonard B Bacharier, Daniel J Jackson
Biologics in the treatment of asthma in children and adolescents. The Journal of allergy and clinical immunology 151 (3) (2023)
Cullen M Dutmer, Andrew H Liu
Knowledge gaps and future opportunities for biologics in childhood allergic and immunologic disorders. The Journal of allergy and clinical immunology 151 (3) (2023)
Thomas Bieber
In search of the Holy Grail in atopic dermatitis: Will dupilumab become the first disease-modifying atopic dermatitis drug? The Journal of allergy and clinical immunology 151 (3) (2023)
Marie Siwicki, Paul Kubes
Neutrophils in host defense, healing, and hypersensitivity: Dynamic cells within a dynamic host. The Journal of allergy and clinical immunology 151 (3) (2023)
Sayantani B Sindher, Suzanne Barshow, Jyothi Tirumalasetty, Stefania Arasi, Dan Atkins, Maureen Bauer, Philippe Bégin, Margaret H Collins, Antoine Deschildre, Alfred D Doyle, Alessandro Fiocchi, Glenn T Furuta, Maria Garcia-Lloret, Maurizio Mennini, Marc E Rothenberg, Jonathan M Spergel, Julie Wang, Robert A Wood, Benjamin L Wright, Torsten Zuberbier, Andrew R Chin, Andrew Long, Kari C Nadeau, R Sharon Chinthrajah
The role of biologics in pediatric food allergy and eosinophilic gastrointestinal disorders. The Journal of allergy and clinical immunology 151 (3) (2023)
Cullen M Dutmer, Andrew H Liu
Knowledge gaps and future opportunities for biologics in childhood allergic and immunologic disorders. The Journal of allergy and clinical immunology 151 (3) (2023)
Leonard B Bacharier, Daniel J Jackson
Biologics in the treatment of asthma in children and adolescents. The Journal of allergy and clinical immunology 151 (3) (2023)
Raffaele De Palma
Patients with CVID have their own "gut feeling" for viruses. The Journal of allergy and clinical immunology 151 (3) (2023)
Marie Siwicki, Paul Kubes
Neutrophils in host defense, healing, and hypersensitivity: Dynamic cells within a dynamic host. The Journal of allergy and clinical immunology 151 (3) (2023)
Hans Bisgaard, Bo Chawes, Jakob Stokholm, Marianne Mikkelsen, Ann-Marie Malby Schoos, Klaus Bønnelykke
25 Years of translational research in the Copenhagen Prospective Studies on Asthma in Childhood (COPSAC). The Journal of allergy and clinical immunology 151 (3) (2023)
Roxane Labrosse, Elie Haddad
Immunodeficiency secondary to biologics. The Journal of allergy and clinical immunology 151 (3) (2023)
Roxane Labrosse, Elie Haddad
Immunodeficiency secondary to biologics. The Journal of allergy and clinical immunology 151 (3) (2023)
Yan Du, Meng Liu, Peter A Nigrovic, Fatma Dedeoglu, Pui Y Lee
Biologics and JAK inhibitors for the treatment of monogenic systemic autoinflammatory diseases in children. The Journal of allergy and clinical immunology 151 (3) (2023)

volume 151, number 5, 2023

Andrew W Liu, Jacob E Gillis, Tina L Sumpter, Daniel H Kaplan
Neuroimmune interactions in atopic and allergic contact dermatitis. The Journal of allergy and clinical immunology 151 (5) (2023)
Andrew W Liu, Jacob E Gillis, Tina L Sumpter, Daniel H Kaplan
Neuroimmune interactions in atopic and allergic contact dermatitis. The Journal of allergy and clinical immunology 151 (5) (2023)
Andrew W Liu, Jacob E Gillis, Tina L Sumpter, Daniel H Kaplan
Neuroimmune interactions in atopic and allergic contact dermatitis. The Journal of allergy and clinical immunology 151 (5) (2023)

volume 151, number 6, 2023

Elena Goleva
Predicting the future: Early-life biomarkers of atopic dermatitis. The Journal of allergy and clinical immunology 151 (6) (2023)

The Journal of allergy and clinical immunology

Keyphrases

Publications

2023

volume 152, number 4, 2023

volume 151, number 1, 2023

volume 151, number 2, 2023

volume 151, number 3, 2023

volume 151, number 5, 2023

volume 151, number 6, 2023